Table 3.
Recommendations for surveillance of non-cirrhotic livers |
---|
European Association for study of the liver (EASL) |
Hepatitis B virus carriers (HBV) |
Adults with family history of HCC (Asian or African) |
Adults with active viral replication (Asian or African) |
Hepatitis C virus (HCV) |
Bridging fibrosis (Metavir F3) and above |
American Association for Study of the Liver (AASLD) |
HBV carriers |
Family history of HCC |
African/North American black |
Female Asian aged >50 years and male Asian aged >40 years |
Uncertain benefit |
Asian HBV <40-year-old male or 50-year-old female |
HCV with bridging fibrosis (Metavir F3) and above |
Noncirrhotic, nonalcoholic fatty liver disease (NAFLD) |
Asian Pacific Association for Study of the Liver (APASL) |
No recommendations for surveillance of non-cirrhotic population |
Abbreviation: HCC, hepatocellular carcinoma.